This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 May;4(5):252-3.

doi: 10.1038/ncpuro0779. Epub 2007 Mar 27.

Do tumor characteristics and prognostic factors differ between subsequent rounds of PSA screening for prostate cancer?

Paul Maroni¹, E David Crawford

Affiliations

PMID: 17389883
DOI: 10.1038/ncpuro0779

Comment

Do tumor characteristics and prognostic factors differ between subsequent rounds of PSA screening for prostate cancer?

Paul Maroni et al. Nat Clin Pract Urol. 2007 May.

. 2007 May;4(5):252-3.

doi: 10.1038/ncpuro0779. Epub 2007 Mar 27.

Authors

Paul Maroni¹, E David Crawford

Affiliation

¹ Section of Urologic Oncology, University of Colorado Health Sciences Center, CO, USA.

PMID: 17389883
DOI: 10.1038/ncpuro0779

No abstract available

PubMed Disclaimer

Comment on

Tumor characteristics and prognostic factors in two subsequent screening rounds with four-year interval within prostate cancer screening trial, ERSPC Rotterdam.
van der Cruijsen-Koeter IW, Roobol MJ, Wildhagen MF, van der Kwast TH, Kirkels WJ, Schröder FH. van der Cruijsen-Koeter IW, et al. Urology. 2006 Sep;68(3):615-20. doi: 10.1016/j.urology.2006.03.015. Urology. 2006. PMID: 17010732 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal